526 related articles for article (PubMed ID: 17646408)
21. [Function and mechanism of tumor suppressor gene FBW7 in tumorigenesis].
Huang HJ; Zheng F; Xu FP; Liu YH; Zhuang HG
Zhonghua Bing Li Xue Za Zhi; 2013 Mar; 42(3):214-6. PubMed ID: 23769449
[No Abstract] [Full Text] [Related]
22. Role of the ubiquitin ligase Fbw7 in cancer progression.
Cheng Y; Li G
Cancer Metastasis Rev; 2012 Jun; 31(1-2):75-87. PubMed ID: 22124735
[TBL] [Abstract][Full Text] [Related]
23. Phosphorylation-dependent degradation of c-Myc is mediated by the F-box protein Fbw7.
Yada M; Hatakeyama S; Kamura T; Nishiyama M; Tsunematsu R; Imaki H; Ishida N; Okumura F; Nakayama K; Nakayama KI
EMBO J; 2004 May; 23(10):2116-25. PubMed ID: 15103331
[TBL] [Abstract][Full Text] [Related]
24. The intracellular domain of Jagged-1 interacts with Notch1 intracellular domain and promotes its degradation through Fbw7 E3 ligase.
Kim MY; Jung J; Mo JS; Ann EJ; Ahn JS; Yoon JH; Park HS
Exp Cell Res; 2011 Oct; 317(17):2438-46. PubMed ID: 21820430
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA-223 regulates cyclin E activity by modulating expression of F-box and WD-40 domain protein 7.
Xu Y; Sengupta T; Kukreja L; Minella AC
J Biol Chem; 2010 Nov; 285(45):34439-46. PubMed ID: 20826802
[TBL] [Abstract][Full Text] [Related]
26. The glomuvenous malformation protein Glomulin binds Rbx1 and regulates cullin RING ligase-mediated turnover of Fbw7.
Tron AE; Arai T; Duda DM; Kuwabara H; Olszewski JL; Fujiwara Y; Bahamon BN; Signoretti S; Schulman BA; DeCaprio JA
Mol Cell; 2012 Apr; 46(1):67-78. PubMed ID: 22405651
[TBL] [Abstract][Full Text] [Related]
27. Control of hematopoietic stem cell quiescence by the E3 ubiquitin ligase Fbw7.
Thompson BJ; Jankovic V; Gao J; Buonamici S; Vest A; Lee JM; Zavadil J; Nimer SD; Aifantis I
J Exp Med; 2008 Jun; 205(6):1395-408. PubMed ID: 18474632
[TBL] [Abstract][Full Text] [Related]
28. The F-box protein Fbw7 is required for cerebellar development.
Jandke A; Da Costa C; Sancho R; Nye E; Spencer-Dene B; Behrens A
Dev Biol; 2011 Oct; 358(1):201-12. PubMed ID: 21827743
[TBL] [Abstract][Full Text] [Related]
29. The impact of NOTCH1, FBW7 and PTEN mutations on prognosis and downstream signaling in pediatric T-cell acute lymphoblastic leukemia: a report from the Children's Oncology Group.
Larson Gedman A; Chen Q; Kugel Desmoulin S; Ge Y; LaFiura K; Haska CL; Cherian C; Devidas M; Linda SB; Taub JW; Matherly LH
Leukemia; 2009 Aug; 23(8):1417-25. PubMed ID: 19340001
[TBL] [Abstract][Full Text] [Related]
30. Regulating Fbw7 on the road to cancer.
Xu W; Taranets L; Popov N
Semin Cancer Biol; 2016 Feb; 36():62-70. PubMed ID: 26459133
[TBL] [Abstract][Full Text] [Related]
31. Oncogenic mutations in the FBXW7 gene of adult T-cell leukemia patients.
Yeh CH; Bellon M; Pancewicz-Wojtkiewicz J; Nicot C
Proc Natl Acad Sci U S A; 2016 Jun; 113(24):6731-6. PubMed ID: 27247421
[TBL] [Abstract][Full Text] [Related]
32. PI3K-dependent phosphorylation of Fbw7 modulates substrate degradation and activity.
Schülein C; Eilers M; Popov N
FEBS Lett; 2011 Jul; 585(14):2151-7. PubMed ID: 21620836
[TBL] [Abstract][Full Text] [Related]
33. NOTCH1/FBXW7 mutation identifies a large subgroup with favorable outcome in adult T-cell acute lymphoblastic leukemia (T-ALL): a Group for Research on Adult Acute Lymphoblastic Leukemia (GRAALL) study.
Asnafi V; Buzyn A; Le Noir S; Baleydier F; Simon A; Beldjord K; Reman O; Witz F; Fagot T; Tavernier E; Turlure P; Leguay T; Huguet F; Vernant JP; Daniel F; Béné MC; Ifrah N; Thomas X; Dombret H; Macintyre E
Blood; 2009 Apr; 113(17):3918-24. PubMed ID: 19109228
[TBL] [Abstract][Full Text] [Related]
34. ERK kinase phosphorylates and destabilizes the tumor suppressor FBW7 in pancreatic cancer.
Ji S; Qin Y; Shi S; Liu X; Hu H; Zhou H; Gao J; Zhang B; Xu W; Liu J; Liang D; Liu L; Liu C; Long J; Zhou H; Chiao PJ; Xu J; Ni Q; Gao D; Yu X
Cell Res; 2015 May; 25(5):561-73. PubMed ID: 25753158
[TBL] [Abstract][Full Text] [Related]
35. Tumor suppressor activities of the Fbw7 E3 ubiquitin ligase receptor.
Fuchs SY
Cancer Biol Ther; 2005 May; 4(5):506-8. PubMed ID: 15908780
[TBL] [Abstract][Full Text] [Related]
36. Nucleophosmin and its AML-associated mutant regulate c-Myc turnover through Fbw7 gamma.
Bonetti P; Davoli T; Sironi C; Amati B; Pelicci PG; Colombo E
J Cell Biol; 2008 Jul; 182(1):19-26. PubMed ID: 18625840
[TBL] [Abstract][Full Text] [Related]
37. Infrequent mutations of Archipelago (hAGO, hCDC4, Fbw7) in primary ovarian cancer.
Kwak EL; Moberg KH; Wahrer DC; Quinn JE; Gilmore PM; Graham CA; Hariharan IK; Harkin DP; Haber DA; Bell DW
Gynecol Oncol; 2005 Jul; 98(1):124-8. PubMed ID: 15913747
[TBL] [Abstract][Full Text] [Related]
38. The Fbw7 and betaTRCP E3 ubiquitin ligases and their roles in tumorigenesis.
Lau AW; Fukushima H; Wei W
Front Biosci (Landmark Ed); 2012 Jun; 17(6):2197-212. PubMed ID: 22652772
[TBL] [Abstract][Full Text] [Related]
39. A TRAIL receptor-dependent synthetic lethal relationship between MYC activation and GSK3beta/FBW7 loss of function.
Rottmann S; Wang Y; Nasoff M; Deveraux QL; Quon KC
Proc Natl Acad Sci U S A; 2005 Oct; 102(42):15195-200. PubMed ID: 16210249
[TBL] [Abstract][Full Text] [Related]
40. The stomatin-like protein SLP-1 and Cdk2 interact with the F-Box protein Fbw7-γ.
Zhang W; MacDonald EM; Koepp DM
PLoS One; 2012; 7(10):e47736. PubMed ID: 23082202
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
